Profiling Mycobacterium tuberculosis transmission and the resulting disease burden in the five highest tuberculosis burden countries

Romain Ragonnet, James M Trauer, Nicholas Geard, Nick Scott, Emma S McBryde, Romain Ragonnet, James M Trauer, Nicholas Geard, Nick Scott, Emma S McBryde

Abstract

Background: Tuberculosis (TB) control efforts are hampered by an imperfect understanding of TB epidemiology. The true age distribution of disease is unknown because a large proportion of individuals with active TB remain undetected. Understanding of transmission is limited by the asymptomatic nature of latent infection and the pathogen's capacity for late reactivation. A better understanding of TB epidemiology is critically needed to ensure effective use of existing and future control tools.

Methods: We use an agent-based model to simulate TB epidemiology in the five highest TB burden countries-India, Indonesia, China, the Philippines and Pakistan-providing unique insights into patterns of transmission and disease. Our model replicates demographically realistic populations, explicitly capturing social contacts between individuals based on local estimates of age-specific contact in household, school and workplace settings. Time-varying programmatic parameters are incorporated to account for the local history of TB control.

Results: We estimate that the 15-19-year-old age group is involved in more than 20% of transmission events in India, Indonesia, the Philippines and Pakistan, despite representing only 5% of the local TB incidence. According to our model, childhood TB represents around one fifth of the incident TB cases in these four countries. In China, three quarters of incident TB were estimated to occur in the ≥ 45-year-old population. The calibrated per-contact transmission risk was found to be similar in each of the five countries despite their very different TB burdens.

Conclusions: Adolescents and young adults are a major driver of TB in high-incidence settings. Relying only on the observed distribution of disease to understand the age profile of transmission is potentially misleading.

Keywords: Infectious disease; Social mixing; Transmission profile; Tuberculosis.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Schematic illustration of the agent-based model. The upper panel represents the structure of the simulated population and the diverse types of contacts simulated (household, school, workplace, other location). The lower panel illustrates individuals’ progression through the various stages of life and infection/disease using diamonds to represent events and boxes for extended phases. Solid arrows indicate deterministic progressions that occur in all surviving individuals, while dashed arrows represent possible but not universal progressions. *Only a fraction of the individuals enters the organised workforce
Fig. 2
Fig. 2
Validation of model outputs against prevalence survey estimates for the age-specific TB prevalence in Indonesia (2014), China (2010), the Philippines (2016) and Pakistan (2011). No data were available for the less than 15-year-old individuals from these surveys. Error bars represent the 95% confidence intervals of the survey estimates (in purple) and the 95% simulation intervals resulting from the stochastic variability of the model and the parameter uncertainty (in green)
Fig. 3
Fig. 3
Contributions of the various locations to the burden of contact and transmission. Error bars represent the 95% simulation intervals
Fig. 4
Fig. 4
Age-specific pattern of social mixing and transmission
Fig. 5
Fig. 5
Age distribution of latent tuberculosis infection. Coloured discs should be interpreted as spheres (to increase the relative size of the smaller spheres), with the volume of the spheres being proportional to the following quantities: 2018 total population (grey), size of the LTBI pool in 2018 (green), and number of individuals currently infected in 2018 who will ever develop active TB (purple). The numbers surrounding each disc indicate the age categories represented. Note that LTBI prevalence is predicted to reach extremely high levels among the oldest age category, which is explained by the high historical intensity of transmission in these countries and by the fact that we do not incorporate LTBI clearance
Fig. 6
Fig. 6
Age distribution of TB cases. The population age distribution (green) was captured at the starting time of analysis (year 2018). Age of TB cases at activation (red) was recorded over a period of 5 years starting from 2018. Error bars represent the 95% simulation intervals obtained for the TB age distribution

References

    1. WHO. Global Tuberculosis Report 2018. Geneva, Switzerland: World Health Organization; 2018.
    1. Dodd PJ, Gardiner E, Coghlan R, Seddon JA. Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. Lancet Glob Health. 2014;2(8):e453–e459. doi: 10.1016/S2214-109X(14)70245-1.
    1. Lillebaek T, Dirksen A, Baess I, Strunge B, Thomsen VO, Andersen AB. Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J Infect Dis. 2002;185(3):401–404. doi: 10.1086/338342.
    1. Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 2016;13(10):e1002152. doi: 10.1371/journal.pmed.1002152.
    1. Gomes MG, Franco AO, Gomes MC, Medley GF. The reinfection threshold promotes variability in tuberculosis epidemiology and vaccine efficacy. Proc Biol Sci. 2004;271:617–623. doi: 10.1098/rspb.2003.2606.
    1. Ferguson NM, Cummings DA, Cauchemez S, Fraser C, Riley S, Meeyai A, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature. 2005;437(7056):209–214. doi: 10.1038/nature04017.
    1. Geard N, Glass K, McCaw JM, McBryde ES, Korb KB, Keeling MJ, et al. The effects of demographic change on disease transmission and vaccine impact in a household structured population. Epidemics. 2015;13:56–64. doi: 10.1016/j.epidem.2015.08.002.
    1. Trauer JM, Dodd PJ, Gomes MGM, Gomez GB, Houben RM, McBryde ES, et al. The importance of heterogeneity to the epidemiology of tuberculosis. Clin Infect Dis. 2019;69(1):159–166. 10.1093/cid/ciy938.
    1. Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008;5(3):e74. doi: 10.1371/journal.pmed.0050074.
    1. Horby P, Pham QT, Hens N, Nguyen TT, Le QM, Dang DT, et al. Social contact patterns in Vietnam and implications for the control of infectious diseases. PLoS One. 2011;6(2):e16965. doi: 10.1371/journal.pone.0016965.
    1. Grijalva CG, Goeyvaerts N, Verastegui H, Edwards KM, Gil AI, Lanata CF, et al. A household-based study of contact networks relevant for the spread of infectious diseases in the highlands of Peru. PLoS One. 2015;10(3):e0118457. doi: 10.1371/journal.pone.0118457.
    1. Eames KT. Modelling disease spread through random and regular contacts in clustered populations. Theor Popul Biol. 2008;73(1):104–111. doi: 10.1016/j.tpb.2007.09.007.
    1. McCreesh N, White RG. An explanation for the low proportion of tuberculosis that results from transmission between household and known social contacts. Sci Rep. 2018;8(1):5382. doi: 10.1038/s41598-018-23797-2.
    1. Siler W. A competing-risk model for animal mortality. Ecology. 1979;60(4):750–757. doi: 10.2307/1936612.
    1. Prem K, Cook AR, Jit M. Projecting social contact matrices in 152 countries using contact surveys and demographic data. PLoS Comput Biol. 2017;13(9):e1005697. doi: 10.1371/journal.pcbi.1005697.
    1. Goeyvaerts N, Santermans E, Potter G, Torneri A, Van Kerckhove K, Willem L, Aerts M, Beutels P and Hens N. Household members do not contact each other at random: implications for infectious disease modelling. Proc R Soc B. 2018;285(1893). 10.1098/rspb.2018.2201.
    1. Ragonnet R, Trauer JM, Scott N, Meehan MT, Denholm JT, McBryde ES. Optimally capturing latency dynamics in models of tuberculosis transmission. Epidemics. 2017;21:39–47. doi: 10.1016/j.epidem.2017.06.002.
    1. Tiemersma EW, van der Werf MJ, Borgdorff MW, Williams BG, Nagelkerke NJ. Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS One. 2011;6(4):e17601. doi: 10.1371/journal.pone.0017601.
    1. Behr MA, Warren SA, Salamon H, Hopewell PC, Ponce de Leon A, Daley CL, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet. 1999;353(9151):444–449. doi: 10.1016/S0140-6736(98)03406-0.
    1. Tostmann A, Kik SV, Kalisvaart NA, Sebek MM, Verver S, Boeree MJ, et al. Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands. Clin Infect Dis. 2008;47(9):1135–1142. doi: 10.1086/591974.
    1. Donald PR. Childhood tuberculosis: the hidden epidemic. Int J Tuberc Lung Dis. 2004;8(5):627–629.
    1. Marais BJ, Gie RP, Schaaf HS, Beyers N, Donald PR, Starke JR. Childhood pulmonary tuberculosis: old wisdom and new challenges. Am J Respir Crit Care Med. 2006;173(10):1078–1090. doi: 10.1164/rccm.200511-1809SO.
    1. Nguipdop-Djomo P, Heldal E, Rodrigues LC, Abubakar I, Mangtani P. Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study. Lancet Infect Dis. 2016;16(2):219–226. doi: 10.1016/S1473-3099(15)00400-4.
    1. Abubakar I, Pimpin L, Ariti C, Beynon R, Mangtani P, Sterne JA, et al. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guerin vaccination against tuberculosis. Health Technol Assess. 2013;17(37):1–372. doi: 10.3310/hta17370.
    1. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA. 1994;271(9):698–702. doi: 10.1001/jama.1994.03510330076038.
    1. Andrews JR, Noubary F, Walensky RP, Cerda R, Losina E, Horsburgh CR. Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. Clin Infect Dis. 2012;54(6):784–791. doi: 10.1093/cid/cir951.
    1. The United Nations - Population Division . Household size and composition. 2017.
    1. Republic of The Philippines Department of Education . Number of schools. 2018.
    1. Shaweno D, Karmakar M, Alene KA, Ragonnet R, Clements AC, Trauer JM, et al. Methods used in the spatial analysis of tuberculosis epidemiology: a systematic review. BMC Med. 2018;16(1):193. doi: 10.1186/s12916-018-1178-4.
    1. China Ministry of Education . Number of schools. 2018.
    1. The World Bank . World Bank and education in Indonesia. 2014.
    1. Pakistan Education Statistics . Number of schools. 2016.
    1. The World Bank . Labor force participation rate. 2018.
    1. Zumla A, Raviglione M, Hafner R, von Reyn CF. Tuberculosis. N Engl J Med. 2013;368(8):745–755. doi: 10.1056/NEJMra1200894.
    1. WHO . Global tuberculosis report 2017. Geneva: World Health Organization; 2017.
    1. Official country estimates of immunization coverage for the year 2016. 2018. Available from: . [cited 30/04/2018].
    1. WHO. Tuberculosis country profiles. Geneva; 2017. Available from:
    1. Belkina TV, Khojiev DS, Tillyashaykhov MN, Tigay ZN, Kudenov MU, Tebbens JD, et al. Delay in the diagnosis and treatment of pulmonary tuberculosis in Uzbekistan: a cross-sectional study. BMC Infect Dis. 2014;14:624. doi: 10.1186/s12879-014-0624-y.
    1. Sreeramareddy CT, Qin ZZ, Satyanarayana S, Subbaraman R, Pai M. Delays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review. Int J Tuberc Lung Dis. 2014;18(3):255–266. doi: 10.5588/ijtld.13.0585.
    1. Asefa A, Teshome W. Total delay in treatment among smear positive pulmonary tuberculosis patients in five primary health centers, southern Ethiopia: a cross sectional study. PLoS One. 2014;9(7):e102884. doi: 10.1371/journal.pone.0102884.
    1. Jurcev-Savicevic A, Mulic R, Kozul K, Ban B, Valic J, Bacun-Ivcek L, et al. Health system delay in pulmonary tuberculosis treatment in a country with an intermediate burden of tuberculosis: a cross-sectional study. BMC Public Health. 2013;13:250. doi: 10.1186/1471-2458-13-250.
    1. Trauer JM, Moyo N, Tay EL, Dale K, Ragonnet R, McBryde ES, et al. Risk of active tuberculosis in the five years following infection . . . 15%? Chest. 2016;149(2):516–525. doi: 10.1016/j.chest.2015.11.017.
    1. Sloot R, Schim van der Loeff MF, Kouw PM, Borgdorff MW. Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam. Am J Respir Crit Care Med. 2014;190(9):1044–1052. doi: 10.1164/rccm.201406-1159OC.
    1. WHO. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva, Switzerland: World Health Organization; 2018.
    1. Union T . UN General Assembly adopts first-ever political agenda for ending tuberculosis epidemic. 2018.
    1. Huynh GH, Klein DJ, Chin DP, Wagner BG, Eckhoff PA, Liu R, et al. Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease. BMC Med. 2015;13:88. doi: 10.1186/s12916-015-0341-4.

Source: PubMed

3
Se inscrever